Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: Evidence for a defect in hepatic glucokinase activity

Diabetes

Volumn 49, Issue 2, 2000, Pages 272-283

  Basu, Ananda ^a   Basu, Rita ^a   Shah, Pankaj ^a   Vella, Adrian ^a   Johnson, C Michael ^a   Nair, K Sreekumaran ^a   Jensen, Michael D ^a   Schwenk, W Frederick ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN; SOMATOSTATIN;

ADULT; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0033985724     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.272     Document Type: Article

References (88)

1. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
2. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J Clin Invest 76:149-155, 1985
3. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
4. Butler PC, Kryshak EJ, Marsh M, Rizza RA: Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NTDDM. Diabetes 39:1373-1380, 1990
5. Kelley DE, Mokan M, Mandarino LJ: Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698-706, 1992
6. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Guilli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1996
7. Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R: The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95:755-762, 1995
8. Aoki TT, Vlachokosta FV, Foss MC, Meistas MT: Evidence for restoration of hepatic glucose processing in type I diabetes mellitus. J Clin Invest 71:937-939, 1983
9. Rizza RA, Mandarino LJ, Gerich JE: Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes 30:990-995, 1981
10. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C: Impaired basal glucose effectiveness in NTDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46:421-432, 1997
11. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA: Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687-697, 1997
12. Wajchenberg BL, Santomauro ATMG, Porrelli RN: Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Res Clin Pract 20:147-154, 1993
13. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Naga I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
14. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA: Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747, 1998
15. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest 100:2354-2361, 1997
16. Felig P, Wahren J, Hendler R: Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes 27:121-126, 1978
17. 31P NMR studies of glucose transport in human skeletal muscle. Proc Natl Acad Sci U S A 95:1313-1318, 1998
18. 13C NMR method to assess intracellular glucose concentration in muscle in vivo. Am J Physiol 274:E381-E389, 1998
19. Saccomani MP, Bonadonna RC, Bier DM, DeFronzo RA, Cobelli C: A model to measure insulin effects on glucose transport and phosphorylation in musde: a three-tracer study. Am J Physiol 270:E170-E185, 1996
20. m, glucose transporter of islets of Langerhans is functionally similar to the low-affinity transporter of liver and has an identical primary sequence. J Biol Chem 265:6548-6551, 1990
21. Gould GW, Holman GD: The glucose transporter family: structure, function, and tissue-specific expression. Biochem J 295:329-341, 1993
22. Yki-Jarvinen H, Mott D, Young AA, Stone K, Bogardus C: Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Inivest 80:95-100, 1987
23. Nuttall FQ, Theen JW, Niewoehner C, Gilboe DP: Response of liver glycogen synthase and phosphorylase to in vivo glucose and glucose analogues. Am J Physiol 245:E521-E527, 1983
24. Witters LA, Avruch J: Insulin regulation of hepatic glycogen synthase and phosphorylase. Biochemistry 17:406-410, 1978
25. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239-245, 1991
26. Ciudad CJ, Massague J, Guinovart JJ: The inactivation of glycogen phosphorylase is not a prerequisite for the activation of liver glycogen synthase. FEBS Lett 99:321-324, 1979
27. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GL Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209, 1998
28. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
29. Giaccari A, Rossetti L: Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest 89:36-45, 1992
30. Cherrington AD, Williams PE, Abou-Mourad N, Lacy WW, Steiner KE, Liljenquist JE: Insulin as a mediator of hepatic glucose uptake in the conscious dog. Am J Physiol 242:E97-E101, 1982
31. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA: Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 77: 1525-1532, 1986
32. Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79-85, 1988
33. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
34. Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43:1549-1557, 1994
35. Wajngot A, Chandramouli V, Schumann WC, Efendic S, Landau BR: Quantitation of glycogen/glucose-1-P cycling in liver. Metabolism 40:877-881, 1991
36. Magnusson I, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR: Pathways of hepatic glycogen formation in humans following ingestion of a glucose load in the fed state. Metabolism 38:583-585, 1989
37. Hellerstein MK, Kaempfer S, Reid JS, Wu K, Shackleton CHL Rate of glucose entry into hepatic uridine diphosphoglucose by the direct pathway in fasted and fed states in normal humans. Metabolism 44:172-182, 1995
38. Hellerstein MK, Greenblatt DJ, Munro HN: Glycoconjugates as noninvasive probes of intrahepatic metabolism. I. Kinetics of label incorporation with evidence of a common precursor UDP-glucose pool for secreted glycoconjugates. Metabolism 36:988-994, 1987
39. Hellerstein MK, Munro HN: Glycoconjugates as noninvasive probes of intrahepatic metabolism. II. Application to measurement of plasma α 1-acid glycoprotein turnover during inflammation. Metabolism 36:995-1000, 1987
40. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, Letscher A: Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans: a stable isotope study. J Clin Invest 100:1305-1319, 1997
41. Shulman GI, Cline G, Shumann WC, Chandramouli V, Kumaran K, Landau BR: Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am J Physiol 259:E335-E341, 1990
42. Rother KI, Schwenk WF: Hepatic glycogen accurately reflected by acetaminophen glucuronide in dogs refed after fasting. Am J Physiol 269:E766-E773, 1995
43. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97:210-213, 1982
44. Meek SE, Persson M, Ford GC, Nair KS: Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 47:1824-1835, 1998
45. Meek SE, Nair KS, Jensen MD: Insulin regulation of regional free fatty acid metabolism. Diabetes 48:10-14, 1999
46. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034, 1988
47. Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM: Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 258:E16-E23, 1990
48. Butler PC, Caumo A, Zerman A, O'Brien PC, Cobeili C, Rizza RA: Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol 264:E548-E569, 1993
49. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
50. Jensen MD, Kanaley JA, Reed JE, Sheedy PF: Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr 61:274-278, 1995
51. Leevy CM, Mendenhall CL, Lesko W, Howard MM: Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169-1179, 1962
52. Steele R, Wall JS, De Bodo RC, Altszuler N, Kiang SP, Bjerknes C: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
53. Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA: Assessment of hepatic sensitivity to glucagon in NIDDM. Diabetes 46:2007-2016, 1997
54. Roden M, Perseghin G, Petersen KF, Hwang J-H, Cline GW, Gerow K, Rothman DL, Shulman GI: The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642-648, 1996
55. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, Hu M: Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. J Clin Invest 92:1126-1134, 1993
56. Goodpaster BH, Thaete FL, Simoneau J-A, Kelley DE: Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579-1585, 1997
57. Bonora E, Prato S, Bonadonna RC, Gulli G, Solini A, Shank ML, Ghiatas AA, Lancaster JL, Kilcoyne RF, Alyassin AM, DeFronzo RA: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151-1159, 1992
58. Gautier J-F, Mouier A, de Kerviler E, Tarentola A, Bigard A, Vellette J-M, Guezennec CY, Cathelineau G: Evaluation of abdominal fat distribution in non-insulin-dependent diabetes mellitus: relationship to insulin resistance. J Clin Endocrinol Metab 83:1306-1311, 1998
59. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
60. Abate N, Garg A, Reshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM: Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 45:1684-1693, 1996
61. Blackshear PJ, Roussell AM, Cohen AM, Nathan DM: Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes: aprospective crossover trial. Diabetes Care 12:455-463, 1989
62. Wajchenberg BL, Nery M, Lerne CE, Silveira AA, Fioratti P, Germek OA: Effect of prolonged glyclazide treatment on blood glucose and plasma insulin responses in obese patients with maturity-onset diabetes. Clin Pharmacol Ther 27:375-378, 1980
63. Shapiro ET, Polonsky KS, Copinschi G, Bosson D, Tillil H, Blackman J, Lewis G, Van Cauter E: Nocturnal elevation of glucose levels during fasting in non-insulin-dependent diabetes. J Clin Endocrinol Metab 72:444-454, 1991
64. Owens DR, Biggs PI, Shetty KJ, Wragg KG: The effect of glibenclamide on the glucose and insulin profile in maturity-onset diabetics following both acute and long-term treatment. Diabetes Metab 6:219-224, 1980
65. Margolis RN, Selawry HP, Curnow RT: Regulation of hepatic glycogen metabolism: effects of diabetes, insulin infusion, and pancreatic islet transplantation. Metabolism 34:62-68, 1985
66. Miller TB Jr: Glucose activation of liver glycogen synthase. Biochim Biophys Acta 583:36-46, 1978
67. Whitton PD, Hems DA: Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats. Biochem J 150:153-165, 1975
68. Wise SD, Nielson MF, Cryer PE, Rizza RA: Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 83:2461-2469, 1998
69. Ekberg K, Landau BR, Wajngot A, Chandraniouli V, Efendic S, Brunengraber H, Wahren J: Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 48:292-298, 1999
70. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J: Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624, 1998
71. Cersosimo E, Judd RL, Miles JM: Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 93:2584-2589, 1994
72. Katz J, McGarry JD: The glucose paradox: is glucose a substrate for liver metabolism? J Clin Invest 74:1901-1909, 1984
73. Magnusson I, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR: Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load. J Clin Invest 80:1748-1754, 1987
74. Velho G, Petersen KF, Perseghin G, Hwang J-H, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755-1761, 1996
75. Brichard SM, Henquin JC, Girard J: Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia 36:292-298, 1993
76. Burcelin R, Eddouks M, Kande J, Assan R, Girard J: Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem J 288:675-679, 1992
77. Caro JF, Triester S, Patel VK, Tapscott EB, Leggett Frazier N, Dohm GL: Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27:19-22, 1985
78. Mueckler M: Facultative glucose transporters. Eur J Biochem 219:713-725, 1994
79. Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI: Liver glycogen turnover in fed and fasted humans. Am J Physiol 266:E796-E803, 1994
80. David M, Petit WA, Laughlin MR, Shulman RG, King JE, Barrett EJ: Simultaneous synthesis and degradation of rat liver glycogen. J Clin Invest 86:612-617, 1990
81. Iynegjian PB, Marie S, Gjinovici A, Genin B, Deng S-P, Buhler L, Morel P, Mentha G: Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver: regulation of gene expression in cultured hepatocytes. J Clin Invest 95:1966-1973, 1995
82. Wang Z-M, Visser M, Ma R, Baumgartner RN, Kotler D, Gallagher D, Heymsfield SB: Skeletal muscle mass: evaluation of neutron activation and dual-energy X-ray absorptiometry methods. J Appl Physiol 80:824-831, 1996
83. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988, 1997
84. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB: High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46:215-223, 1997
85. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364, 1999
86. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
87. Mandarino LJ, Printz RL, Cusi KA, Kinchington P, O'Doherty RM, Osawa H, Sewell C, Consoli A, Granner DK, DeFronzo RA: Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol (Endocrinol Melab) 269:E701-E708, 1995
88. Printz R, Koch S, Potter L, O'Doherty R, Tiesinga J, Moritz S, Granner D: Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. J Biol Chem 268:5209-5219, 1993